JP2006511211A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511211A5 JP2006511211A5 JP2004538747A JP2004538747A JP2006511211A5 JP 2006511211 A5 JP2006511211 A5 JP 2006511211A5 JP 2004538747 A JP2004538747 A JP 2004538747A JP 2004538747 A JP2004538747 A JP 2004538747A JP 2006511211 A5 JP2006511211 A5 JP 2006511211A5
- Authority
- JP
- Japan
- Prior art keywords
- expression construct
- seq
- dna expression
- acid sequence
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004414 DNA Proteins 0.000 claims 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical group 0.000 claims 5
- 241000714165 Feline leukemia virus Species 0.000 claims 4
- 108010052285 Membrane Proteins Proteins 0.000 claims 4
- 102000018697 Membrane Proteins Human genes 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 241000282324 Felis Species 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 101710172711 Structural protein Proteins 0.000 claims 2
- 239000005547 deoxyribonucleotide Substances 0.000 claims 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10244863 | 2002-09-23 | ||
| PCT/DE2003/003179 WO2004028562A2 (de) | 2002-09-23 | 2003-09-19 | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006511211A JP2006511211A (ja) | 2006-04-06 |
| JP2006511211A5 true JP2006511211A5 (enExample) | 2006-11-09 |
| JP4411213B2 JP4411213B2 (ja) | 2010-02-10 |
Family
ID=32038184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004538747A Expired - Fee Related JP4411213B2 (ja) | 2002-09-23 | 2003-09-19 | ネコ白血病ウィルスによるネコ感染症のようなオンコウィルス感染症に対するワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7915035B2 (enExample) |
| EP (1) | EP1553977B1 (enExample) |
| JP (1) | JP4411213B2 (enExample) |
| AT (1) | ATE335507T1 (enExample) |
| AU (1) | AU2003281917A1 (enExample) |
| DE (2) | DE50304603D1 (enExample) |
| DK (1) | DK1553977T3 (enExample) |
| ES (1) | ES2270120T3 (enExample) |
| WO (1) | WO2004028562A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0901593D0 (en) * | 2009-01-30 | 2009-03-11 | Touchlight Genetics Ltd | Production of closed linear DNA |
| US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
| GB201013153D0 (en) | 2010-08-04 | 2010-09-22 | Touchlight Genetics Ltd | Primer for production of closed linear DNA |
| RS58289B1 (sr) * | 2011-07-20 | 2019-03-29 | Merial Ltd | Rekombinantna vakcina protiv virusa mačje leukemije koja sadrži optimizovani gen omotača virusa mačje leukemije |
| EP3706789A1 (en) | 2017-11-06 | 2020-09-16 | Intervet International B.V. | Feline calicivirus vaccine |
| CA3080427A1 (en) * | 2017-11-06 | 2019-05-09 | Intervet International B.V. | Feline leukemia virus vaccine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU607399B2 (en) * | 1985-09-09 | 1991-03-07 | Cetus Corporation | Infectious recombinant virus vaccine for feline leukemia |
| AU672359B2 (en) * | 1991-03-07 | 1996-10-03 | Virogenetics Corporation | Genetically engineered vaccine strain |
| FR2751223B1 (fr) * | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
| DE19648625A1 (de) * | 1996-11-13 | 1998-05-14 | Soft Gene Gmbh | Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer |
| US6696291B2 (en) * | 1997-02-07 | 2004-02-24 | Merck & Co., Inc. | Synthetic HIV gag genes |
| US6248582B1 (en) * | 1997-10-08 | 2001-06-19 | Imran Khan | Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| SE9803099D0 (sv) * | 1998-09-13 | 1998-09-13 | Karolinska Innovations Ab | Nucleic acid transfer |
| WO2003031470A2 (de) * | 2001-10-02 | 2003-04-17 | Mologen Ag | Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose |
-
2003
- 2003-09-19 DE DE50304603T patent/DE50304603D1/de not_active Expired - Lifetime
- 2003-09-19 DK DK03773451T patent/DK1553977T3/da active
- 2003-09-19 EP EP03773451A patent/EP1553977B1/de not_active Expired - Lifetime
- 2003-09-19 AT AT03773451T patent/ATE335507T1/de active
- 2003-09-19 WO PCT/DE2003/003179 patent/WO2004028562A2/de not_active Ceased
- 2003-09-19 ES ES03773451T patent/ES2270120T3/es not_active Expired - Lifetime
- 2003-09-19 JP JP2004538747A patent/JP4411213B2/ja not_active Expired - Fee Related
- 2003-09-19 DE DE10393824T patent/DE10393824D2/de not_active Expired - Fee Related
- 2003-09-19 AU AU2003281917A patent/AU2003281917A1/en not_active Abandoned
- 2003-09-23 US US10/528,748 patent/US7915035B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190315642A1 (en) | Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome | |
| JP3830525B2 (ja) | 組織横断輸送を強化するペプチドとその同定法および使用法 | |
| JPWO2022067130A5 (enExample) | ||
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| US9676641B2 (en) | Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses | |
| JP2012532601A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2004503213A5 (enExample) | ||
| JP2020510426A5 (enExample) | ||
| JP2010512160A5 (enExample) | ||
| JP2007516696A5 (enExample) | ||
| AU2025205053A1 (en) | Compositions including Sbi adjuvants and methods of use thereof | |
| JP2006511211A5 (enExample) | ||
| CN116782928A (zh) | 能够将抗原递送至mhc-ii途径并在宿主中诱导cd4+和cd8+t细胞应答的慢病毒载体 | |
| FR2726576A1 (fr) | Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante | |
| JP2002536418A5 (enExample) | ||
| CN116209771A (zh) | 用于改善疫苗接种的组合物和方法 | |
| CN104404069B (zh) | 一种低拷贝pTerm质粒及其构建方法和应用 | |
| JP2008521384A (ja) | コロナウィルス様粒子をコードする発現ベクター | |
| WO2002068662A8 (en) | Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method | |
| JP2003334089A5 (enExample) | ||
| CN112725378A (zh) | 一种人工改造的akt3环状rna及其在新冠疫苗中的应用 | |
| JP2005526511A5 (enExample) | ||
| ATE458037T1 (de) | Grosstechnisch geeigneter mikroorganismus | |
| FI117897B (fi) | Punkin kantaman aivotulehdus- (TBE) viruksen tarttuva cDNA-klooni, siitä saatu yhdistelmä-DNA-rokote ja tämän valmistus |